The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Open accessAbstract
Cisplatin is a platinum-based chemotherapeutic agent that induces peripheral neuropathy in 30% of patients. Peripheral neuropathy is the dose limiting side effect, which has no preventative therapy. We have previously shown that cisplatin induces apoptosis in dorsal root ganglion (DRG) sensory neurons by covalently binding to nuclear DNA (nDNA), resulting in DNA damage, subsequent p53 activation and Bax-mediated apoptosis via the mitochondria. We now demonstrate that cisplatin also directly binds to mitochondrial DNA (mtDNA) with the same binding affinity as nDNA. Cisplatin binds 1 platinum molecule per 2166 mtDNA base pairs and 1 platinum molecule per 3800 nDNA base pairs. Furthermore, cisplatin treatment inhibits mtDNA replication as detected by 5-bromo-2'-deoxy-uridine (BrdU) incorporation and inhibits transcription of mitochondrial genes. The relative reduction in mtDNA transcription is directly related to the distance the gene is located from the transcription initiation point, which implies that randomly formed platinum adducts block transcription. Cisplatin treated DRG neurons exhibit mitochondrial vacuolization and degradation in vitro and in vivo. Taken together, this data suggests that direct mtDNA damage may provide a novel, distinct mechanism for cisplatin-induced neurotoxicity separate from the established nDNA damage pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ
Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H. W., Terada, S., Nakata, T., Takei, Y., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00363-4 · Cited by 767
Replication and Transcription of Vertebrate Mitochondrial DNA
Clayton, D. A. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.002321 · Cited by 635
Chemotherapy‐induced neuropathy
Windebank, A. J., & Grisold, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00156.x · Cited by 613
Self-citationEastman, A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90009-x · Cited by 539
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
Thompson, S. W., Davis, L. E., Kornfeld, M., Hilgers, R. D., & Standefer, J. C. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7<1269::aid-cncr2820540707>3.0.co;2-9 · Cited by 394
Furda, A., Santos, J. H., Meyer, J. N., & Van Houten, B. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-62703-739-6_31 · Cited by 384
Ta, L. E., Espeset, L., Podratz, J., & Windebank, A. J. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.04.010 · Cited by 325
Self-citationSantos, J. H., Meyer, J. N., Mandavilli, B. S., & Houten, B. (2008) · Methods in Molecular Biology · doi:10.1385/1-59259-973-7:183 · Cited by 285
Gill, J. S., & Windebank, A. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1130 · Cited by 278
Self-citationIn situ localization of mitochondrial DNA replication in intact mammalian cells.
Davis, A. F., & Clayton, D. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.4.883 · Cited by 262
Mitochondrial DNA repair pathways
Croteau, D. L., Stierum, R. H., & Bohr, V. A. (1999) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00025-7 · Cited by 240
McDonald, E. S., Randon, K. R., Knight, A., & Windebank, A. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.013 · Cited by 227
Self-citationMitochondrial transcription and its regulation in mammalian cells
Asin-Cayuela, J., & Gustafsson, C. M. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.01.003 · Cited by 223
Ta, L. E., Bieber, A. J., Carlton, S. M., Loprinzi, C. L., Low, P. A., & Windebank, A. J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-15 · Cited by 193
Self-citationTa, L. E., Low, P. A., & Windebank, A. J. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-9 · Cited by 164
Self-citationMcDonald, E. S., & Windebank, A. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0468 · Cited by 135
Self-citationCisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
Meijer, C., de Vries, E. G. E., Marmiroli, P., Tredici, G., Frattola, L., & Cavaletti, G. (1999) · PubMed · Cited by 104
Progressive paresthesias after cessation of therapy with very high-dose cisplatin
Grunberg, S. M., Sonka, S., Stevenson, L. L., et al. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00694340 · Cited by 82
Inhibition of axonal growth from sensory neurons by excess nerve growth factor
Conti, A. M. F., Fischer, S. J., & Windebank, A. J. (1997) · Annals of Neurology · doi:10.1002/ana.410420604 · Cited by 70
Self-citationLentz, S. I., Edwards, J. L., Backus, C., McLean, L. L., Haines, K. M., & Feldman, E. L. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954701 · Cited by 63
Effect of cisplatin and ACTH4–9 on neural transport in cisplatin induced neurotoxicity
Russell, J. W., Windebank, A. J., McNiven, M. A., Brat, D. J., & Brimijoin, W. S. (1995) · Brain Research · doi:10.1016/0006-8993(95)00100-5 · Cited by 53
Self-citationLiang, B. C., & Ullyatt, E. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400401 · Cited by 44
Bottone, M. G., Soldani, C., Veneroni, P., Avella, D., Pisu, M. B., & Bernocchi, G. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00530.x · Cited by 43
Cited by
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
Neuropathic Pain: From Mechanisms to Treatment
Finnerup, N. B., Kuner, R., & Jensen, T. S. (2021) · Physiological Reviews · doi:10.1152/physrev.00045.2019 · Cited by 1,558
Chemotherapy-induced peripheral neuropathy: a current review
Staff, N. P., Grisold, A., Grisold, W., & Windebank, A. J. (2017) · Annals of Neurology · doi:10.1002/ana.24951 · Cited by 908
Self-citationMechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Marullo, R., Werner, E., Degtyareva, N., Moore, B., Altavilla, G., Ramalingam, S. S., & Doetsch, P. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081162 · Cited by 777
Metadata
- Authors
- Podratz, J. L., Knight, A. M., Ta, L. E., Staff, N. P., Gass, J. M., Genelin, K., Schlattau, A., Lathroum, L., & Windebank, A. J.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 41
- Issue
- 3
- Pages
- 661-668
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2058983865
- Cited by
- 320
- References
- 24
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.